Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy

Eye

Volumn 20, Issue 12, 2006, Pages 1366-1369

  Demircan, N ^a   Safran, B G ^b   Soylu, M ^a   Ozcan, A A ^a   Sizmaz, S ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

^b Department of Ophthalmology Numune Hospital ^*  (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; NEOVASCULARIZATION (PATHOLOGY); PROTEIN DETERMINATION; SERUM; VITRECTOMY; VITREORETINOPATHY; VITREOUS BODY;

EID: 33845546564     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6702138     Document Type: Article

References (25)

1. Limb GA, Chignell AH, Green W, LeRoy F, Dumonde DC. Distribution of TNF-alpha and its reactive vascular adhesion molecules in fibrovascular membranes of proliferative diabetic retinopathy. Br J Ophthalmol 1996; 80: 168-173.
2. Limb GA, Soomro H, Janikoun S, Hollifield RD, Shilling J. Evidence for control of tumour necrosis factor-alpha (TNF-α) activity by TNF receptors in patients with proliferative diabetic retinopathy. Clin Exp Immunol 1999; 115: 409-414.
3. Wiedemann P. Growth factors in retinal diseases: Proliferative vitreoretinopathy, proliferative diabetic retinopathy and retinal degeneration. Surv Ophthalmol 1992; 36: 373-384.
4. Aksunger A, Akbatur H, Or M, Güven D, Okur H, Hasanreisoglu B. The role of interleukin-8 in pathogenesis of advanced proliferative diabetic retinopathy. Ret-vit 1994; 2: 63-66.
5. Ben Ezra D, Hemo I, Maftzir G. In vivo angiogenic activity of interleukins. Arch Ophthalmol 1990; 108: 573-576.
6. Ferrick MR, Thurau SR, Oppenheim MH, Herbort CP, Ni MingNi, Zachariae COC et al. Ocular inflammation stimulated by intravitreal interleukin-8 and interleukin-1. Invest Ophthalmol Vis Sci 1991; 32: 1534-1539.
7. Akduman L, Or M, Hasanreisoglu B, Gokcora N, Kaplan HJ. Intravitreal interleukin-8 (IL-8) in uveitis. Ret-vit 1994; 2: 279-284.
8. Hoekzema R, Murray PI, Kijlstra A. Cytokines and intraocular inflammation. Curr Eye Res 1990; 9: 207-211.
9. Bhattacherjee P, Henderson B. Inflammatory responses to intraocularly injected interleukin 1. Curr Eye Res 1987; 6: 929-933.
10. Funatsu H, Yamashita H, Shimizu E, Kojima R, Hori S. Relationship between vascular endothelial growth factor and interleukin-6 in diabetic retinopathy. Retina 2001; 21: 469-477.
11. Enler GS, Enler VM, Jaffe GJ, Stuart A, Kunkel S, Strieter RM. Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. Curr Eye Res 1995; 22: 1045-1053.
12. Reichel E, Duker JS. Diabetic vitrectomy. Curr Opin Opthalmol 1994; 5(3): 50-53.
13. Davis DM. Proliferative diabetic retinopathy. In: Ryan SJ (ed). Retina. The CV Mosby Company: St Louis, 1994, pp 1319-1360.
14. Limb GA, Little BC, Meager A, Ogilvie JA,Wolstencroft RA, Franks WA et al. Cytokines in proliferative vitreoretinopathy. Eye 1991; 5: 686-693.
15. Arend WP, Daye JM. Cytokines and growth factors. In: Kelley WN, Harris ED (eds). Textbook of Rheumatology. WB Saunders Comp: Philadelphia, 1993, pp 227-246.
16. Ideta R, Yamashita H, Tanaka Y, Kato S, Kitano S, Hori S. Roles of cytokines in diabetic retinopathy. Arch Ophthalmol 1999; 117(5): 700-701.
17. Kojima S, Yamada T, Tamai M. Quantitative analysis of interleukin-6 in vitreous from patients wit proliferative vitreoretinal diseases. Jpn J Ophthalmol 2001; 45: 40-45.
18. Cicik E, Tekin H, Akar S, Ekmekci OB, Donma Koldas L, Ozkan S. Interleukin-8, nitric oxide, and glutathione status in proliferative vitreoretinopathy and proliferative diabetic retinopathy. Ophthal Res 2003; 35: 251-255.
19. Limb GA, Webster H, Soomro S, Janikoun S, Shilling J. Platelet expression of tumour necrosis factor-alpha (TNF-α), TNF receptors and intercellular adhesion molecule-1 (ICAM-1) in patients with proliferative diabetic retinopathy. Clin Exp Immunol 1999; 118(2): 213-218.
20. Doganay S, Evereklioglu C, Er H, Turkoz Y, Sevinc A, Mehmet N et al. Comparison of serum NO, TNF-α, IL-1 β, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus. Eye 2002; 16: 163-170.
21. Rosenbaum JT, Samples JR, Hefeneider SH, Hower EL. Ocular inflammatory effects of intravitreal interleukin 1. Arch Ophthalmol 1987; 105: 1117-1120.
22. Abu el Asrar AM, Maimone D, Morse PH, Gregory S, Reder AT. Cytokines in the vitreous of patients with proliferative diabetic retinopathy. Am J Ophthalmol 1992; 114: 731-736.
23. Kauffmann DJ, Meurs JC, Mertens AE, Peperkamp E, Master GME. Cytokines in vitreous humor: Interleukin-6 elevated in proliferative vitroretinopathy. Invest Ophthalmol 1994; 35: 900-906.
24. Rosenbaum JT, Howes EL, Rubin RM, Samples JR. Ocular inflammatory effects of intravitreally-injected tumor necrosis factor. Am J Pathology 1988; 133: 47-53.
25. Elner VM, Scales W, Elner SG, Danforth J, Kunkel SL, Strieter RM. Interleukin-6 (IL-6) gene expression and secretion by cytokine-stimulated human retinal pigment epithelial cells. Exp Eye Res 1992; 54: 361-368.